PharmaBlock Sciences (Nanjing) Company Description

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production.

It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial.

The company was founded in 2006 and is based in Nanjing, the People's Republic of China.

PharmaBlock Sciences (Nanjing), Inc.

Country	China
Founded	2006
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	2,455
CEO	Minmin Yang

Contact Details

Address: 10 Xuefu Road Nanjing, 210032 China
Phone	86 40 0025 5188
Website	pharmablock.com

Stock Details

Ticker Symbol	300725
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000035K5
SIC Code	8731

Key Executives

Name	Position
Dr. Minmin Yang Ph.D.	Co-Founder, Chairman and Chief Executive Officer
Wu Yifei	Secretary, Chief Financial Officer and Accounting Supervisor
Dr. Shijie Zhang Ph.D.	Chief Technology Officer
Dr. Jing Li Ph.D.	Senior Vice President of Process Chemistry and President of PharmaBlock (USA), Inc.
Dr. Shuhai Zhao Ph.D.	Co-founder and Chief Scientific Officer
Dr. David Chen Ph.D.	Executive Vice President, Chief Operation Officer and Head of CDMO
Dr. Dezhi Sha Ph.D.	Senior Vice President of Process Technology and Manufacturing